-
-
-
-
-
-
-
SciSparc subsidiary files patent application for depression treatment
-
-
-
-
-
-
-
SciSparc to acquire GERD device portfolio from Xylo Technologies
-
-
-
-
-
-
-
N2OFF completes acquisition of cancer drug discovery firm MitoCareX
-
-
-
-
-
-
-
SciSparc shareholders approve merger with Israeli auto importer AutoMax
-
-
-
-
-
-
-
SciSparc (SPRC) Announces Publication of Japanese Patent Application
-
-
-
-
-
-
-
SciSparc (SPRC) Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
-
-
-
-
-
-
-
SciSparc (SPRC) Secures FDA Green Light to US Launch of Phase IIb Clinical Trial for Tourette Syndrome Treatment
-
458,219 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

